Loading clinical trials...

COMPLETEDNCT01462448

Study to Identify the Genetic Variations Associated With Phantom Limb Pain

The purpose of this study is to determine if there is a genetic component to phantom limb pain. DNA will be analyzed for single nucleotide polymorphisms (SNPs) between the control and phantom limb pai...

Lead sponsor: Henry M. Jackson Foundation for the Advancement of Military Medicine•1 U.S. locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Related studies

RECRUITINGPhase 2/3

Clinical Trial Exploring the Outpatient Treatment of Phantom Limb Pain With Ketamine Administration in a Six Month Study With a Minimum Remission Period of 7 Days Between Treatment Session. 25-30 Subjects With an Ongoing History of Significant PLP.--FDA and IRB Approved.

NCT07276542 · Phantom Limb Syndrome With Pain

RECRUITING

Evaluation of RPNI for Symptomatic Neuromas in Lower Limb Amputees

NCT07420192 · Symptomatic Neuroma, Phantom Limb Pain After Amputation, and more

RECRUITINGNA

Clinical Application Observation on the Evaluation of Phantom Limb Pain With the Suralis System

NCT07324109 · Phantom Limb Pain After Amputation, Lower Limb Amputation Above Knee, and more

RECRUITINGNA

Immersive Healing: The Therapeutic Potential of Virtual Reality

NCT06077227 · Phantom Limb Pain (PLP)

RECRUITINGNA

Pragmatic Trial of Remote tDCS and Somatosensory Training for Phantom Limb Pain With Machine Learning to Predict Treatment Response

NCT05188183 · Phantom Limb Pain

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: August 12, 2025Terms

Trial snapshot

StatusCOMPLETED

Phase—

Enrollment726

Start dateMar 2012

Last updatedAug 12, 2025

Condition

Phantom Limb

Locations shown

Walter Reed National Military Medical Center (WRNMMC)

Bethesda, Maryland

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: August 12, 2025Data synced to Clareo: June 28, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions

Study to Identify the Genetic Variations Associated With Phantom Limb Pain

What this study is about

Save this trial guide to your notes

Sponsors

Related studies

Clinical Trial Exploring the Outpatient Treatment of Phantom Limb Pain With Ketamine Administration in a Six Month Study With a Minimum Remission Period of 7 Days Between Treatment Session. 25-30 Subjects With an Ongoing History of Significant PLP.--FDA and IRB Approved.

Evaluation of RPNI for Symptomatic Neuromas in Lower Limb Amputees

Clinical Application Observation on the Evaluation of Phantom Limb Pain With the Suralis System

Immersive Healing: The Therapeutic Potential of Virtual Reality

Pragmatic Trial of Remote tDCS and Somatosensory Training for Phantom Limb Pain With Machine Learning to Predict Treatment Response

Trial snapshot

Condition

Locations shown

For caregivers